The Chase Group is proud to partner with Eisai and support their human health care mission by securing a strong and agile leader for their Global Oncology Business Unit. The new Senior Medical Director is driving the medical affairs portfolio and team for the Women’s Cancer Care, Oncology Business Unit. Drawn to Eisai’s patient-focused business mindset, this new medical lead has hit the ground running, contributing to finding innovative solutions in disease prevention, treatment, and care for the health and wellbeing of people worldwide. To learn more about how The Chase Group can help you secure high caliber executive talent, please contact Moira Newbanks at moira@chasegroup.com for more information.
Partnership With The Chase Group Results in Successful Placement for Eisai Global Oncology Business Unit
The Chase Group is proud to partner with Eisai and support their human health care mission by securing a strong and agile leader for their Global Oncology Business Unit. The new Senior Medical Director is driving the medical affairs portfolio and team for the Women’s Cancer Care, Oncology Business Unit. Drawn to Eisai’s patient-focused business mindset, this new medical lead has hit the ground running, contributing to finding innovative solutions in disease prevention, treatment, and care for the health and wellbeing of people worldwide. To learn more about how The Chase Group can help you secure high caliber executive talent, please contact Moira Newbanks at moira@chasegroup.com for more information.- Categories: Life Sciences, Pharmaceutical
Ionis Director, Global HEOR, Rare Disease Immunology, Successfully Placed by The Chase Group
Ami Claxton, MS, PhD has joined Ionis Pharmaceuticals, Inc. as Director, Global HEOR Rare Disease Immunology. She will play a critical and significant role as…
Successful Placement at Avidity
The Chase Group is pleased to announce the successful completion of the Vice President, Medical Affairs search for Avidity Biosciences. Nathan Weedin brings 15+ years…
The Chase Group Successfully Completes Search for Amyloidosis Medical Affairs Leader
Ionis Pharmaceuticals has a 35-year track record of perfecting and advancing RNA-targeted drug discovery and development. Projecting a vast number of new transformational products on…
The Chase Group Identifies Chief Medical Officer for Arcturus Therapeutics
In late 2022, Arcturus Therapeutics retained The Chase Group to build out additions to the leadership team. Tasked with identifying the new Chief Medical Officer,…
The Chase Group Secures VP, Head of Regulatory Affairs, for Checkmate Pharmaceuticals
The Chase Group is pleased to announce the successful recruitment of Elvis Osei Tutu, PharmD, as the Vice President, Head of Regulatory Affairs at Checkmate…
The Chase Group Secures Clinical Operations Leadership for Alexza Pharmaceuticals
The Chase Group, committed to executive recruitment in life sciences, is pleased to announce the completion of another search for Alexza Pharmaceuticals, successfully securing Mike…